MA
FBIO icon

MYDA Advisors’s Fortress Biotech FBIO Stock Holding History

MYDA Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-37,000
Closed -$63.3K – 161
2024
Q2 		$63.3K Hold
37,000
– – 0.01% 121
2024
Q1 		$74K Buy
+37,000
New +$73.6K 0.02% 111

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MYDA Advisors's FBIO Position: Q3 2024 in Review

MYDA Advisors sold out of Fortress Biotech (FBIO) in Q3 2024, closing a stake of 37,000 shares — an estimated $63.3K sold.

MYDA Advisors first reported a position in FBIO in Q1 2024 and held it in 2 quarters. The position peaked at $74K in Q1 2024. 50 funds tracked by Wall St. Rank hold FBIO as of Q3 2024.

  • MYDA Advisors reported no remaining Fortress Biotech position as of Q3 2024 after selling out during the quarter.
  • MYDA Advisors sold 37,000 Fortress Biotech shares in Q3 2024, an estimated $63.3K.
  • MYDA Advisors first reported a position in Fortress Biotech in Q1 2024 and held it in 2 quarters.
  • MYDA Advisors's Fortress Biotech position peaked at $74K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2024.

Based on MYDA Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.